PlainRecalls
FDA Devices Moderate Class II Ongoing

cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems; Material Number 09446125190

Reported: February 15, 2023 Initiated: December 21, 2022 #Z-1105-2023

Product Description

cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems; Material Number 09446125190

Reason for Recall

The firm received customer complaints regarding false negative Influenza A (Flu A) results and late Flu A Target Ct values. A false negative influenza A result may lead to additional testing, psychological distress, and delays to targeted therapy for influenza as well as true diagnosis.

Details

Units Affected
9,948 OUS only
Distribution
Domestic distribution nationwide. Foreign distribution worldwide.
Location
Branchburg, NJ

Frequently Asked Questions

What product was recalled?
cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems; Material Number 09446125190. Recalled by Roche Molecular Systems, Inc.. Units affected: 9,948 OUS only.
Why was this product recalled?
The firm received customer complaints regarding false negative Influenza A (Flu A) results and late Flu A Target Ct values. A false negative influenza A result may lead to additional testing, psychological distress, and delays to targeted therapy for influenza as well as true diagnosis.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 15, 2023. Severity: Moderate. Recall number: Z-1105-2023.